VeriSIM Life logo

VeriSIM Life

VeriSIM was founded in 2017 by Dr. Jo Varshney, a multidisciplinary and celebrated leader in veterinary & human health development. Together with a team of world-class scientists, machine learning engineers and in silicon simulation experts the team is bringing clarity to drug development through computational sciences rather than the existing trial and error experimentation approach. 
The leadership believes that with their machine learning-driven approach, they can  pre-flight advancements in medicine without the need for redundant trials, subjecting animals to the cruelty of testing, and with far better outcomes than the  8% success currently seen in medicine making it to market. More people will be able to receive the treatments they require and our partners will see faster and verified results from their research.

Content by VeriSIM Life

A hand reaching out to touch an artificial projection of another hand, mirrored
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue